dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Weller, Karsten |
dc.contributor.author | Gimenez-Arnau , Ana M |
dc.contributor.author | Baron, Jens |
dc.contributor.author | Brehler, Randolf |
dc.contributor.author | Ferrer, Marta |
dc.contributor.author | Groffik, Adriane |
dc.contributor.author | Labrador-Horrillo, Moises |
dc.date.accessioned | 2024-01-29T08:09:58Z |
dc.date.available | 2024-01-29T08:09:58Z |
dc.date.issued | 2024-01 |
dc.identifier.citation | Weller K, Gimenez-Arnau AM, Baron J, Brehler R, Ferrer M, Groffik A, et al. Efficacy and safety of on-demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial. Allergy. 2024 Jan;79(1):93–103. |
dc.identifier.issn | 0105-4538 |
dc.identifier.uri | https://hdl.handle.net/11351/10923 |
dc.description | Urticària crònica espontània; Sota demanda; Rupatadina |
dc.description.sponsorship | This study was funded in part by URIACH, and the analysis was funded by Charité—Universitätsmedizin Berlin as part of the “CU-LATER” study. Other features of the study were supported by intramural funding. In addition, this study benefited from the network of Urticaria Centers of Reference and Excellence (UCAREs; https://ga2len-ucare.com) of GA2LEN, the Global Allergy and Asthma European Network. |
dc.language.iso | eng |
dc.publisher | Wiley |
dc.relation.ispartofseries | Allergy;79(1) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Urticària - Tractament |
dc.subject | Antihistamínics - Ús terapèutic |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Treatment Outcome |
dc.subject.mesh | Urticaria |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Histamine Antagonists |
dc.title | Efficacy and safety of on-demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1111/all.15854 |
dc.subject.decs | resultado del tratamiento |
dc.subject.decs | urticaria |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | antagonistas de los receptores histamínicos |
dc.relation.publishversion | https://doi.org/10.1111/all.15854 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Weller K] Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany. Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. [Gimenez-Arnau AM] Department of Dermatology, Hospital del Mar, IMIM, Universitat Pompeu Fabra, Barcelona, Spain. [Baron J] Department of Dermatology and Allergy, University Hospital, RWTH Aachen, Aachen, Germany. [Brehler R] Department of Dermatology, University Hospital Muenster, Muenster, Germany. [Ferrer M] Department of Allergy, Clinica Universidad de Navarra, Pamplona, Spain. RICORS Red De Enfermedades Inflamatorias, Madrid, Spain. [Groffik A] Department of Dermatology, University Medical Center Mainz, Mainz, Germany. [Labrador-Horrillo M] Servei d’Al·lergologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 37597162 |
dc.identifier.wos | 001051325100001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |